文献速递其他结缔组织病

北美幼年特发性炎症性肌病合并肺孢子菌肺炎的危险因素

Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

本研究通过REDCap问卷收集13例北美合并肺孢子菌肺炎(PJP)的幼年特发性炎症性肌病(JIIM)患者资料,并与147例无PJP的JIIM患者比较。发现PJP与亚裔、抗MDA5抗体、指端梗死、皮肤溃疡、间质性肺病及更强免疫抑制治疗相关,7例入ICU、4例死亡,建议对具有这些特征者考虑预防。

要点

  • 亚裔、抗MDA5抗体、指端梗死、皮肤溃疡和间质性肺病与JIIM合并PJP风险升高相关。
  • PJP确诊前更常接受冲击激素、利妥昔单抗及更多免疫抑制治疗。
  • PJP在JIIM中可致命,具有上述特征者应考虑PJP预防。

核心结论

  • PJP是JIIM中可致命的严重感染,与更强免疫抑制治疗、抗MDA5抗体、亚裔及指端梗死、皮肤溃疡、间质性肺病等特征相关,具有这些特征者应考虑预防。

研究设计与样本

  • 通过REDCap问卷收集北美13例合并PJP的JIIM患者(PJP+)的肌炎特征、病程、用药及PJP感染特点。
  • 将PJP+患者与来自相似地理区域、 enrolled in NIH自然史研究的147例无PJP的JIIM患者(PJP-)进行比较。

主要发现

  • PJP+患者中亚裔血统比例高于PJP-患者(OR 8.7;95% CI 1.3, 57.9)。
  • PJP+患者抗MDA5自身抗体(OR 12.5;95% CI 3.0, 52.4)、指端梗死(OR 43.8;95% CI 4.2, 460.2)、皮肤溃疡(OR 12.0;95% CI 3.5, 41.2)和间质性肺病(OR 10.6;95% CI 2.1, 53.9)更常见。
  • PJP诊断前,PJP+患者更常接受冲击激素、利妥昔单抗及更多免疫抑制治疗。
  • 7例PJP+患者入住ICU,4例死于PJP或其并发症。

关键数值与推荐

  • 亚裔血统OR 8.7(95% CI 1.3, 57.9);抗MDA5抗体OR 12.5(95% CI 3.0, 52.4);指端梗死OR 43.8(95% CI 4.2, 460.2)。
  • 皮肤溃疡OR 12.0(95% CI 3.5, 41.2);间质性肺病OR 10.6(95% CI 2.1, 53.9)。

临床怎么用

  • 对具有亚裔血统、抗MDA5抗体阳性、指端梗死、皮肤溃疡或间质性肺病的JIIM患者,应考虑PJP预防。
  • 对接受冲击激素、利妥昔单抗或较强免疫抑制治疗的JIIM患者,应警惕PJP风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Pneumocystis jirovecii pneumonia (PJP) is associated with significant morbidity and mortality in adult myositis patients; however, there are few studies examining PJP in juvenile myositis [juvenile idiopathic inflammatory myopathy (JIIM)]. The purpose of this study was to determine the risk factors and clinical phenotypes associated with PJP in JIIM. METHODS: An research electronic data capture (REDCap) questionnaire regarding myositis features, disease course, medications and PJP infection characteristics was completed by treating physicians for 13 JIIM patients who developed PJP (PJP+) from the USA and Canada. Myositis features and medications were compared with 147 JIIM patients without PJP (PJP-) from similar geographic regions who enrolled in National Institutes of Health natural history studies. RESULTS: PJP+ patients were more often of Asian ancestry than PJP- patients [odds ratio (OR) 8.7; 95% CI 1.3, 57.9]. Anti- melanoma differentiation associated protein 5 (MDA5) autoantibodies (OR 12.5; 95% CI 3.0, 52.4), digital infarcts (OR 43.8; 95% CI 4.2, 460.2), skin ulcerations (OR 12.0; 95% CI 3.5, 41.2) and interstitial lung disease (OR 10.6; 95% CI 2.1, 53.9) were more frequent in PJP+ patients. Before PJP diagnosis, patients more frequently received pulse steroids, rituximab and more immunosuppressive therapy compared with PJP- patients. Seven PJP+ patients were admitted to the intensive care unit and four patients died due to PJP or its complications. CONCLUSIONS: PJP is a severe infection in JIIM that can be associated with mortality. Having PJP was associated with more immunosuppressive therapy, anti-MDA5 autoantibodies, Asian race and certain clinical features, including digital infarcts, cutaneous ulcerations and interstitial lung disease. Prophylaxis for PJP should be considered in juvenile myositis patients with these features.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Sabbagh SE, Neely J, Chow A, et al. Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America. Rheumatology (Oxford). 2021. PMID: 32889531. doi:10.1093/rheumatology/keaa436

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。